Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00744471 · ClinicalTrials.gov registry record · Phase 3
Tanezumab in Osteoarthritis Of The Hip
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 627
- Enrollment target
NCT00744471 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 627 participants.
The verdict
NCT00744471, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 627 participants
- Enrollment target
Study Summary
The purpose of this study is to test the efficacy and safety of 3 doses of tanezumab in osteoarthritis of the hip in patients
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL tanezumab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 627 participants |
| Start Date | 2008-11-17 |
| Est. Completion | 2010-08-13 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00744471
The ClinicalTrials.gov registry entry for NCT00744471 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 627 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00744471 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00744471 about?
NCT00744471 is a clinical study titled "Tanezumab in Osteoarthritis Of The Hip". The purpose of this study is to test the efficacy and safety of 3 doses of tanezumab in osteoarthritis of the hip in patients
What is the current status of trial NCT00744471?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 627 participants. The study started on 2008-11-17. Estimated completion is 2010-08-13.
What interventions are being tested in trial NCT00744471?
The interventions under investigation include: Placebo (BIOLOGICAL), tanezumab (BIOLOGICAL).
Who is sponsoring clinical trial NCT00744471?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.